KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Deferred Taxes: 2009-2024

Historic Deferred Taxes for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to -$24.2 million.

  • Idexx Laboratories' Deferred Taxes rose 1461.48% to $93.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.4 million, marking a year-over-year increase of 267.16%. This contributed to the annual value of -$24.2 million for FY2024, which is 49.92% up from last year.
  • According to the latest figures from FY2024, Idexx Laboratories' Deferred Taxes is -$24.2 million, which was up 49.92% from -$48.3 million recorded in FY2023.
  • Idexx Laboratories' Deferred Taxes' 5-year high stood at -$3.4 million during FY2021, with a 5-year trough of -$48.3 million in FY2023.
  • In the last 3 years, Idexx Laboratories' Deferred Taxes had a median value of -$35.1 million in 2022 and averaged -$35.9 million.
  • In the last 5 years, Idexx Laboratories' Deferred Taxes skyrocketed by 91.13% in 2021 and then crashed by 938.35% in 2022.
  • Over the past 5 years, Idexx Laboratories' Deferred Taxes (Yearly) stood at -$38.1 million in 2020, then skyrocketed by 91.13% to -$3.4 million in 2021, then crashed by 938.35% to -$35.1 million in 2022, then crashed by 37.76% to -$48.3 million in 2023, then spiked by 49.92% to -$24.2 million in 2024.